Agomelatine - Nectid
Alternative Names: NRT-31; NRT-34; NRT-36Latest Information Update: 30 Jul 2015
At a glance
- Originator Nectid
- Class Acetamides; Antidepressants; Anxiolytics; Behavioural disorder therapies; Hypnosedatives; Sleep disorder therapies; Small molecules
- Mechanism of Action 5-HT2C serotonin receptor antagonists; Melatonin MT1 receptor agonists; Melatonin MT2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Autistic disorder; Fibromyalgia; Multiple sclerosis; Neuropathic pain
Most Recent Events
- 30 Jul 2015 No recent reports on development identified - Clinical-Phase-Unknown for Multiple sclerosis in USA (unspecified route)
- 30 Jul 2015 No recent reports on development identified - Phase-II for Autistic disorder (In children) in USA (unspecified route)
- 30 Jul 2015 No recent reports on development identified - Phase-II for Fibromyalgia in USA (unspecified route)